| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification
|
Cornillie, J.
|
|
|
22 |
4 |
p. 546-554
|
artikel
|
| 2 |
Bemiparin as a long-term treatment for venous thrombosis in cancer patients: the ELEBAMA study
|
Pina, E.
|
|
|
22 |
4 |
p. 616-620
|
artikel
|
| 3 |
Breast cancer and cytomegalovirus
|
Richardson, A. K.
|
|
|
22 |
4 |
p. 585-602
|
artikel
|
| 4 |
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
|
Passaro, A.
|
|
|
22 |
4 |
p. 621
|
artikel
|
| 5 |
Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients
|
Fox, B.
|
|
|
22 |
4 |
p. 555-562
|
artikel
|
| 6 |
Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis
|
Wang, X.
|
|
|
22 |
4 |
p. 468-473
|
artikel
|
| 7 |
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial
|
Quintero Aldana, G.
|
|
|
22 |
4 |
p. 495-502
|
artikel
|
| 8 |
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
|
Passaro, A.
|
|
|
22 |
4 |
p. 603-611
|
artikel
|
| 9 |
Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway
|
Li, G.
|
|
|
22 |
4 |
p. 503-511
|
artikel
|
| 10 |
ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling
|
Xuan, X.
|
|
|
22 |
4 |
p. 563-575
|
artikel
|
| 11 |
Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients
|
Feliu, J.
|
|
|
22 |
4 |
p. 457-467
|
artikel
|
| 12 |
Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy
|
Protopapa, M.
|
|
|
22 |
4 |
p. 447-456
|
artikel
|
| 13 |
Outpatient management of incidental pulmonary embolism in cancer patient
|
Muñoz Martín, Andrés J.
|
|
|
22 |
4 |
p. 612-615
|
artikel
|
| 14 |
Red and processed meat consumption and esophageal cancer risk: a systematic review and meta-analysis
|
Zhao, Z.
|
|
|
22 |
4 |
p. 532-545
|
artikel
|
| 15 |
Resection of liver metastases from breast cancer: a multicentre analysis
|
He, X.
|
|
|
22 |
4 |
p. 512-521
|
artikel
|
| 16 |
Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis
|
Wu, N.
|
|
|
22 |
4 |
p. 474-485
|
artikel
|
| 17 |
Stromal fibroblast-derived MFAP5 promotes the invasion and migration of breast cancer cells via Notch1/slug signaling
|
Chen, Z.
|
|
|
22 |
4 |
p. 522-531
|
artikel
|
| 18 |
The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo
|
Dana, N.
|
|
|
22 |
4 |
p. 486-494
|
artikel
|
| 19 |
The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients
|
Chen, K.
|
|
|
22 |
4 |
p. 576-584
|
artikel
|
Tijdschrift beschrijving